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ABSTRACT: We report the fabrication of aqueous multi-
modal imaging nanocomposites based on superparamagnetic
nanoparticles (MNPs) and two diﬀerent sizes of photo-
luminescent upconverting nanoparticles (UCNPs). The
controlled and simultaneous incorporation of both types of
nanoparticles (NPs) was obtained by controlling the solvent
composition and the addition rate of the destabilizing solvent.
The magnetic properties of the MNPs remained unaltered
after their encapsulation into the polymeric beads as shown by
the T2 relaxivity measurements. The UCNPs maintain
photoluminescent properties even when embedded with the
MNPs into the polymer bead. Moreover, the light emitted by
the magnetic and upconverting nanobeads (MUCNBs) under
NIR excitation (λexc = 980 nm) was clearly observed through diﬀerent thicknesses of agarose gel or through a mouse skin layer.
The comparison with magnetic and luminescent nanobeads based on red-emitting quantum dots (QDs) demonstrated that while
the QD-based beads show signiﬁcant autoﬂuorescence background from the skin, the signal obtained by the MUCNBs allows a
decrease in this background. In summary, these results indicate that MUCNBs are good magnetic and optical probes for in vivo
multimodal imaging sensors.
■ INTRODUCTION
Upconverting nanoparticles (UCNPs) have emerged as
promising probes for biological imaging1−5 due to their
exceptional capacity to emit ultraviolet and visible photons
after being excited by lower-energy photons in the NIR range.
High photochemical stability; deep tissue penetration;6 absence
of autoﬂuorescence; photobleaching; blinking7 and low toxicity
in comparison with traditional ﬂuorescent nanomaterials8 are
other outstanding characteristics of UCNPs. The most eﬃcient
UCNPs are the β-phase NaYF4 doped with a Yb
3+ sensitizer
and a Er3+emitter. In combination with other functional NPs
such as gold NPs9,10 or doping with paramagnetic
Gd3+resulting in NaGdF4:Yb,Er NPs
11,12 they have been
designed as ultrasmall multimodal agents for tumor imaging.
To make dual modal UCNP based probes, in addition to
exploiting the insertion of T1 contrast ions (i.e., Gd3+) into the
NaYF4 matrix, nanocomposites that combine luminescent
UCNPs and MNPs are attracting attention.13,14 This results
in hybrid probes that combine the eﬃcacy of the UCNPs as an
optical imaging probe with the potential applications of MNPs,
not only as T2 contrast agents for MRI, but also for cell sorting
applications and as therapeutic agents (i.e., heat mediators in
magnetic hyperthermia). Diﬀerent strategies have been
exploited for the preparation of magnetic luminescent nano-
composites based on UCNPs and MNPs. Among them, the
cross-linking of MNPs to UCNPs and encapsulation strategies
are the most exploited ones.15 In addition to the encapsulation
strategy using an inorganic shell such as silica beads, polymer-
based clustering is an interesting strategy to combine diﬀerent
NPs without altering their magnetic and luminescent proper-
ties, resulting in water-dispersible and nontoxic nanomateri-
als.16 Furthermore, encapsulation in polymer enables easy
surface functionalization of the resulting nanoclusters to
improve cellular uptake and speciﬁc recognition, among others.
This was demonstrated for instance by wrapping quantum dots
(QDs) and MNPs within polymeric beads with a size of few
hundreds of nanometers decorated with folic acid molecules.17
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In this work we present the preparation of water-soluble
multimodal imaging nanocomposites based on superparamag-
netic iron oxide NPs (IONPs) and two diﬀerent sizes of
lanthanide-doped upconverting nanocrystals. The simultaneous
incorporation of both NPs was done by wrapping them in the
amphiphilic poly(maleic anhydride-alt-1-octadecene), a com-
mercially available polymer, to form a nanobead structure. The
resulting clusters exhibit a tunable size between 80 and 130 nm
depending mainly on the NPs and polymer concentrations. We
proved that upconversion luminescence and magnetic contrast
were still present in the water-soluble hybrid nanocomposites.
Moreover, the light emitted by the nanobeads upon NIR
excitation was observed through diﬀerent thicknesses of agarose
gel and also through a mouse skin layer simulating an in vivo
imaging experiment. In comparison, ﬂuorescent magnetic
nanobeads based on quantum dots emitting light in the visible
region exhibit signiﬁcant background autoﬂuorescence from the
skin, thus demonstrating the higher eﬃcacy of our nanobeads
as in vivo multimodal imaging sensors.
■ RESULTS AND DISCUSSION
Preparation of Magnetic Upconverting Nanobeads
(MUCNBs). 15-nm-sized superparamagnetic IONPs (Figure
1C) were used as magnetic nanomaterials for the nanobead
preparation, and two diﬀerent upconverting nanocrystals of 23
and 7 nm (Figure 1B and D, respectively) were chosen as
luminescent materials. These UCNPs have been demonstrated
by Ostrowski et al.18 to emit at higher energies in the visible
range without sacriﬁcing brightness or stability. To prepare
MUCNBs, 15 nm IONPs and UCNPs (7 or 23 nm) were
mixed in THF with the presence of the poly(maleic anhydride-
alt-1-octadecene). The mixture was shaken for 45 min at room
temperature. During that time, the solvent slowly evaporated,
allowing the initial packing of particles and polymer. At that
point, the controlled addition of a destabilizing solvent like
acetonitrile permitted the clustering of IONPs and UCNPs
together and the almost simultaneous encapsulation by the
polymer, thus resulting in the formation of polymeric beads
containing magnetic and UCNPs (Figure 1A). To remove the
excess of polymer, the as-prepared MUCNBs were placed on a
permanent magnet (0.3 T) overnight. The supernatant was
removed and the solid black pellet containing the nanobeads
was collected to the magnet and resuspended in water. After
the puriﬁcation process, TEM images showed the presence
inside the beads of both magnetic and UCNPs, which are
distinguishable given their diﬀerent sizes (Figure 1E,F). From
these images the MUCNBs exhibit high homogeneity in both
size and nanoparticle distribution. The size of the nanobeads
and the nanoparticle distribution inside the beads depend on
several factors such as nanoparticle and polymer concentration,
shaking time, and the rate of acetonitrile addition. These
conditions were previously optimized for the preparation of
magnetic nanobeads only containing IONPs and resulting in
bead sizes between 80 and 200 nm.19 Preparation of
homogeneous multimodal nanobeads based on diﬀerent kinds
of NPs was conducted by modifying the amount of NPs and
keeping the other parameters constant. By mixing 15 nm
IONPs and 7 nm UCNPs, MUCNBs with hydrodynamic sizes
around 120 nm were obtained. By tuning the nanoparticle
concentration the bead size increased from 80 to 120 nm with a
similar distribution of NPs inside the nanobeads, as
characterized by TEM (see Figure S1 in the Supporting
Information). For the preparation of the MUCNBs based on 15
nm IONPs and 23 nm UCNPs, the same trend was observed.
Larger hydrodynamic sizes ranging from 150 to 160 nm in
ACN were observed immediately after their preparation.
Diameters of 160 to 170 nm were observed after being
transferred into water (Figures S2 and S3). From dynamic light
scattering (DLS) spectra (Figures S3 and Table S1), narrow
peaks are recorded both in ACN and in water, indicating the
absence of aggregates for the MUCNBs and demonstrating the
monodispersion of the MUCNBs in solution. The slight
increase in the hydrodynamic diameter upon transfer from
ACN to water suggests hydration of the polymer shell.
The nanoparticle distribution diﬀered slightly in the
nanobeads containing 23 or 7 nm UCNPs. The TEM image
shows a clustering of few 23 nm UCNPs within the MUCNBs
compared to the 7 nm UCNPs which in the latter case formed
larger clusters inside the nanobeads and were more uniformly
distributed with IONPs (Figure 1E,F). This could be due to a
Figure 1. Scheme for synthesis of MUCNBs (A); TEM images of 23 nm UCNPs (B), 15 nm IONPs (C), 6 nm UCNPs (D), and MUCNBs with 15
nm IONPs and 23 nm UCNPs (E) or 6 nm UCNPs (F).
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diﬀerence in the destabilization of the larger UCNPs with
respect to the smaller MNPs. To deeply investigate this aspect,
MUCNBs were also prepared using larger UCNPs (30−40
nm) and small manganese iron oxide NPs (8 nm). TEM images
of these MUCNBs have indeed shown large clusters of
manganese iron oxide NPs and mostly only 2−3 UCNPs per
bead (Figure S4) thus conﬁrming the more diﬃcult
destabilization of the bigger UCNPs with respect to the
smaller MNPs. In this speciﬁc case, however, given the high
packing density of MNPs around each UCNP within the beads
the photoluminescence was not retained (data not shown).
Confocal Microscopy. To further conﬁrm the success of
the co-clustering of both IONPs and UCNPs in the nanobead
structure and also to verify the retention of the UCNPs’
upconverting luminescence, the MUCNBs were analyzed by
optical spectroscopy, lifetime analysis and confocal microscopy.
Under near-infrared excitation (980 nm, 2 W), MUCNBs
retained the green (520, 540 nm) and red luminescence (653
nm) peaks characteristic of the Yb3+/Er3+-NaYF4 UCNPs. The
653 nm emission of the MUCNBs exhibited an eﬀective
luminescence lifetime of 214.2 ± 0.9 μs, a factor of 2 lower than
the 478 ± 5 μs lifetimes of the nanobeads loaded with only
UCNPs (see Figure S5 and Table S2 in SI for detailed lifetime
data). This reduction in the eﬀective lifetime is due to the
introduction of a second exponential decay component (130
μs) that may represent the nonradiative transfer of energy from
UCNP excited states to adjacent IONPs. Similarly, the green
emission (540 nm) of MUCNBs exhibits a luminescence
lifetime that is 2-fold shorter than beads with only UCNPs.
Although the reduced lifetime at both wavelengths implies a
reduction in upconversion eﬃciency, the fact that the lifetimes
are not reduced more signiﬁcantly allows the MUCNBs to
retain their ability to upconvert NIR light. In fact, typical
MUCNB suspensions were consistently brighter than those
without IONPs because isolation of the magnetic beads from
their reaction solutions was more straightforward.
When drop-cast on a glass coverslip and illuminated under
near-infrared excitation (980 nm), MUCNBs containing both
sizes of UCNPs exhibited bright emission intensity in the
visible region of 500−680 nm (Figure S6). However, the
eﬃciency of the MUCNBs as potential light sensors depends
on the capacity of these luminescent materials to emit visible
light through diﬀerent tissues without increasing the corre-
sponding background from the tissues which slightly absorb
NIR light.8,20,21 Therefore, the MUCNBs were analyzed
through diﬀerent matrixes and thicknesses to emulate the in
vivo conditions. For instance, the MUCNBs deposited on a
glass coverslip were covered with agarose gels of diﬀerent
thicknesses (0.8, 2.0, and 4.0 mm) and then drop-cast again on
top of the gel to study the light penetration. The beads on the
coverslip were used as a reference to focus the confocal image
at the gel base, then images were collected by scanning the
sample along the z axis (z-stack) until the top surface of the gel
was reached. In Figure S7A, the 3D confocal image recorded for
the agarose gel of 0.8 mm thickness is reported. As shown in
Figure 2A and B, the luminescent nanobeads were clearly
observed as yellow spots respectively at 0.8 and 2.0 mm of
thickness upon excitation at 980 nm (Figure S7). These yellow
spots correspond to the MUCNBs as conﬁrmed by the
emission spectra recorded in those regions which present
typical emission peaks of NaYF4:Yb, ErNPs at 520, 540, and
650 nm (Figure 2C). Nevertheless, a further increase of the gel
thickness to 4 mm resulted in poor detection of the nanobeads
(Figure S7B). Therefore, the observed intensity of MUCNBs
upon NIR excitation is directly related to the thickness of the
agarose gel, as a decrease of the emission intensity is observed
with an increasing thickness. However, a high emission
intensity at a very high depth is desirable for cell and tissue
imaging. An excitation at 970 nm with a pulsed laser was
applied through diﬀerent thicknesses of agarose gel up to 5
mm. In this case, the MUCNBs were clearly observed as bright
spots on the top surface of the gel (Figure S8) even through a
Figure 2. Schematic representation of a confocal experiment performed on MUCNBs with 23 nmUCNPs deposited on agarose gel. Confocal
spectral image of MUCNBs with 23 nm UCNPs deposited on an agarose gel of 0.8 mm thickness (A) and 2 mm thickness (B). Emission spectrum
of MUCNBs with 23 nm UCNPs (λexc = 980 nm) (C).
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thickness of 5 mm. Indeed, the stronger excitation power
ensured by the pulsed laser (500 mW mean power) with
respect to the previously used continuous emitting laser (150
mW) enhances the imaging eﬃciency of the MUCNBs. Based
on these results, we sought to evaluate the eﬃciency of these
new luminescent nanoclusters as imaging sensors through a
tissue representative of human skin−mouse skin. For this
purpose, we followed a procedure similar to the one reported in
Figure 2 but substituting the agarose gel with a slice of hairless
mouse skin with a thickness of 0.5 mm. It is well-known that
autoﬂuorescence from the skin interferes in the visualization of
the clusters, thereby decreasing the signal-to-noise ratio and
imaging sensitivity. The main issue arises from the visible light
absorption by the skin, which is negligible in the NIR range. In
fact, the MUCNBs were readily visible through the mouse skin
with a high contrast under NIR excitation, without interference
from the background ﬂuorescence from the skin (Figure 3A).
In contrast, the MFNBs based on quantum dots (488 nm
excitation, 600 nm emission) and imaged under the same
conditions exhibited a high background noise related to the
autoﬂuorescence of the skin, thus reducing the eﬀectiveness of
the QDs as potential in vivo sensors (Figure 3B). Indeed, the
excitation of the mouse skin at the corresponding wavelength of
the MFNBs (488 nm) resulted in autoﬂuorescence in the
visible emission range (520−700 nm), in which the QDs also
emit (Figure S9A). In contrast, the excitation of the mouse skin
at the MUCNBs excitation wavelength (980 nm) produced no
emission in the visible range (Figure S9B), thus indicating a
high signal to the noise ratio upon NIR excitation of the
MUCNBs in medical imaging techniques.
Relaxivity Measurements. As commented above, the
inclusion of both upconverting and iron oxide NPs in the same
nanobead enables the exploitation of the synthesized MUCNBs
as multifunctional imaging sensors. Having demonstrated their
potential application as imaging probes upon NIR excitation,
the MUCNBs were then evaluated as magnetic resonance
imaging22 contrast agents by performing relaxivity measur-
ments.
The IONPs used for the bead preparation have been shown
to have high values for the transverse relaxation rates r2 making
them eﬃcient negative contrast agents for MRI.23 To evaluate if
the clustering process aﬀects the relaxation times of the
magnetic NPs, the r2 values measured for the MUCNBs were
compared with those of the single 15 nm IONPs. The
measurements were performed at two diﬀerent magnetic ﬁelds
(1.5 and 9.4 T). The IONPs were transferred to water as the
NPs were individually coated with the same poly(maleic
anhydride-alt-1-octadecene) used in the MUCNB’s formation.
Similar r2 values were obtained for both MUCNBs and
IONPs. At a low magnetic ﬁeld, 1.5 T, the IONPs presented an
r2 value of 112 mM
−1 s−1, while the MUCNBs exhibited an r2
value of 122 mM−1 s−1. At a high magnetic ﬁeld, 9.4 T, r2 values
of 208 and 206 mM−1 s−1 for single IONPs and MUCNBs were
obtained, respectively (see also Table S3 in SI). These
transverse relaxivity results are in accordance with the values
reported in the literature for individual and clustered IONPs
with sizes similar to those of our nanocomposites.24−26 The
similar capacity of both IONPs and MUCNBs to act as T2
contrast agent for MRI was also qualitatively observed by
imaging the two materials in a multiwell phantom for MRI in
which the two samples were drop-cast at diﬀerent iron
concentrations. Indeed, as shown in Figure 3C, IONCs and
MUCNBs exhibit similar signal decay, that is, similar T2 values,
at the same iron concentration.
Cytotoxicity Assay and Stability in Cell Media. A lactate
dehydrogenase (LDH) membrane integrity assay was per-
formed to measure the cytotoxicity of MUCNBs at diﬀerent
incubation times (12 and 24 h) and with diﬀerent doses. Doses
were based on the elemental analysis of iron (6, 12, and 24 μg
Fe/mL) and the corresponding amounts of yttrium (2.58, 5.17,
and 10.33 μgY/mL) administered to two cancer cell lines
(HeLa-WT cervical cancer cells and A431 epidermoid
carcinoma cells). Within the concentration range chosen,
HeLa-WT cervical cancer cells did not show any sign of
cytotoxicity (<5% toxicity) after 12 and 24 h of incubation
(Figure 4a). A similar trend was also observed when using
A431cells and testing the toxicity at 12 h; a slightly higher
cytotoxicity (ca. 25%) was observed at 24 h (Figure 4b). We
also examined the stability of MUCNBs in the cell culture
media by observing sedimentation at 37 °C. No sedimentation
Figure 3. Confocal images of MUCNBs with UCNPs of 23 nm,
deposited on a slice of mouse skin (thickness 0.5 mm, λexc = 980 nm,
λem = 500−680 nm) (A). Confocal images of MFNBs deposited on a
slice of mouse skin (thickness 0.5 mm, λexc = 480 nm, λem = 640 nm
(B); T2-weighted MR image of magnetic nanoparticles (MNPs) and
magnetic upconverting nanobeads (MUCNBs) at diﬀerent concen-
trations (C).
Figure 4. LDH assay showing the percentage of cytotoxicity as a
function of the concentration of MUCNBs for HeLa-WT cells,
showing no toxicity at 12 and 24 h (a) and for A431 cells, showing a
slight toxicity (25%) at 24 h and no toxicity at 12 h (b). Error bars
represent the standard deviation (n = 3 for all groups). Optical images
(c) of MUCNBs (6 μg Fe/mL) at 0, 1, 3, 6, 12, 24 h of incubation in
phenyl red free DMEM medium containing 10% of FBS. The ﬁrst
panel (control) represents plain DMEM. MUCNBs remain stable in
media for up to 6 h of incubation, after which the bead sample began
to partially sediment.
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was observed for up to 6 h of incubation, while partial sample
sedimentation was observed at 12 and 24 h (Figure 4c). The
hydrodynamic diameters measured in water just after the
exposure of the MUCNBs to cell culture media indicated an
increase in size when prolonging the exposure time in the
media (Figure S10). This size increase can likely be attributed
to the partial absorption of serum proteins that indeed bring to
the partial beads sedimentation and in turn might account for
the slight toxicity observed with the A431 cells at 24 h (Figure
4b). Overall, the trend in the cytotoxicity of the MUCNBs is
consistent with that of magnetic nanobeads that contain only
iron oxide NPs, with the same dose ranges and incubation
times, as we have previously demonstrated (ESI of the work of
R. Di Corato et al.).27
■ CONCLUSIONS
In this work, we have reported the fabrication of water-soluble
nanobeads with both magnetic and upconverting functionality.
The nanobeads were prepared by combining 15 nm iron oxide
NPs with NaYF4:Yb,ErNPs (UCNPs) of two diﬀerent sizes (23
and 7 nm) wrapped together in the amphiphilic poly(maleic
anhydride-alt-1-octadecene). Depending on the concentration
of NPs and polymer, the nanobead size was tunable from 80 to
160 nm. These MUCNBs were successfully imaged through
diﬀerent thicknesses and matrixes upon a near-infrared
excitation wavelength at 980 nm. In comparison to other
ﬂuorescent nanobeads based on QDs, the upconverting
nanobeads did not show the autoﬂuorescent background of
the skin due to the NIR laser as excitation source. Moreover,
these MUCNBs were demonstrated to be outstanding T2
contrast agents at low and high magnetic ﬁelds. The facile
synthesis and ready functionalization of these multifunctional
magnetic and upconverting nanobeads will allow them to be
used in a range of in vivo probes for molecular imaging. Finally,
no signiﬁcant toxicity was observed for the MUCNBs. The
resulting system can be easily used as a starting platform for
further modiﬁcation to obtain more complex hybrid systems.
■ EXPERIMENTAL SECTION
Chemicals. Poly(maleic anhydride-alt-1-octadecene), Mn
30 000−50 000 g/mol (Aldrich), Milli-Q water (18.2 MΩ,
ﬁltered with ﬁlter pore size 0.22 μM) from Millipore,
acetonitrile (HPLC grade, J. T. Baker) and tetrahydrofuran
anhydride (Carlo Erba, p.a.), iron oxide hydroxide (Sigma-
Aldrich, #371254), iron acetylacetonate (Sigma-Aldrich, 99%),
manganese acetylacetonate (Sigma-Aldrich, #245763), hexade-
canediol (Sigma-Aldrich, 90%), dodecylamine (Sigma-Aldrich,
98%), lauric acid (Sigma-Aldrich, 99%), benzyl ether (Sigma-
Aldrich, 98%), and octadecene (Sigma-Aldrich, 90%), YCl3,
YbCl3, ErCl3, ammonium ﬂuoride, and sodium oleate, tri-n-
octylphosphine oxide (Strem, 99%), tri-n-octylphosphine
(Strem, 97%), n-octadecylphosphonic acid (PolyCarbon
Industries, 99%), cadmium oxide (Sigma-Aldrich, 99.99%),
selenium (Sigma-Aldrich, 99.99%), diethylzinc (Sigma-Aldrich,
1 M in hexane) and hexamethyldisilathiane (Sigma-Aldrich,
synthesis grade), ethanol (Sigma-Aldrich, 99.8%), methanol
(Sigma-Aldrich, 99.9%), toluene (Sigma-Aldrich, 99.5%), and
hexane (Sigma-Aldrich, 99%) were used without any further
puriﬁcation. All reagents for cell cytotoxicity assay were
purchased from Gibco (ThermoFisher Scientiﬁc).
Synthesis of 15-nm-size Iron Oxide Nanoparticles
(IONPs). IONPs were prepared following the method
published by Colvin et al.28 Brieﬂy, 0.18 g of iron oxide
hydroxide, 2.3 or 3.45 g of oleic acid (leading to a ratio of oleic
acid to iron oxide hydroxide of 4 or 6, respectively), and 5 g of
octadecene were transferred in a three-necked round-bottom
ﬂask to an under inert gas atmosphere and stirred at 320 °C for
1 h. Finally, the NPs were washed twice by the addition of
ethanol or methanol as nonsolvents followed by centrifugation.
The supernatant was removed and the particles were
redispersed in toluene.
Synthesis of Upconverting NaYF4 Nanoparticles
Doped with Yb3+ and Er3+ (UCNPs). NaYF4:20% Yb
3+, 2%
Er3+ NPs were synthesized in an automated nanoparticle
synthesis robot (WANDA) using the method described by
Ostrowski et al.18 Brieﬂy, a stock solution of rare earth oleates
(78 mol % Y, 20% Yb, 2% Er) was prepared by heating YCl3,
YbCl3, ErCl3, and oleic acid in 1-octadecene under vacuum.
Reactions were performed under nitrogen in WANDA by
adding the stock solution, ammonium ﬂuoride, sodium oleate
to a 40 mL glass vial and heating the vial to 305−318 °C for 45
min while stirring. The nanoparticle product was puriﬁed from
reactants using three cycles of precipitation with ethanol,
centrifuging, and resuspension in hexane. To grow smaller 8
nm UCNPs, oleylamine was added to the ﬁnal reaction
solution.18
Synthesis of 8-nm-size Manganese Iron Oxide Nano-
particles. Manganese iron oxide NPs were prepared by
following a previous paper.29 2 mmol of iron acetylacetonate
was mixed with 1 mmol manganese acetylacetonate, 10 mmol
hexadecanediol, 6 mmol dodecylamine, 6 mmol lauric acid, and
20 mL benzyl ether. The solution was exposed to a ﬂow of
nitrogen and heated to 140 °C for 1 h, then to 210 °C for 2 h,
and ﬁnally to 300 °C for another 1 h. Subsequently, the sample
was washed several times with ethanol, acetone, and
isopropanol as precipitation agents, then centrifuged. The
supernatant was removed and the particles redispersed in
toluene.
Synthesis of 6-nm-size Cadmium Selenide-Zinc
Sulﬁde Core−Shell Quantum Dots (QDs). Cadmium
selenide-zinc sulﬁde QDs were prepared in a two-step process
according to some modiﬁcations of already published
protocols.30,31 Nearly monodisperse 5 nm CdSe QDs were
synthesized by mixing them in a 50 mL ﬂask with 3.0 g of
trioctylphosphine oxide,32 0.280 g of n-octadecylphosphonic
acid (ODPA), and 0.060 g of cadmium oxide.33 The reaction
mixture was heated to ca. 150 °C and exposed to vacuum for ca.
1 h. Then, under nitrogen atmosphere, the solution was heated
to above 300 °C to dissolve the CdO until it turned optically
clear and colorless. At this point, 1.5 g of TOP was injected into
the ﬂask and the temperature was increased to 380 °C for the
injection of the Se:TOP solution (0.058 g Se + 0.360 g TOP).
The reaction was stopped after 1 min to synthesize the red
ﬂuorescent CdSe QDs. To form the ZnS shell, the temperature
of the reaction was decreased to 120 °C and a solution of 450
μL of diethylzinc (ZnEt2) and 125 μL of hexamethyldisilathiane
((TMS)2S) dissolved in 1.5 mL of TOP was injected dropwise
into the reaction ﬂask.
The temperature was then increased to 200 °C for 10 min
under stirring. The mixture was cooled down to 90 °C and 3
mL of toluene were added. After the synthesis, the nanocrystals
were washed by repeated dissolution in toluene and
precipitation with the addition of methanol and, ﬁnally, they
were dissolved in toluene.
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Synthesis of Magnetic Upconverting Nanobeads
(MUCNBs) with UCNPs of 23 and 7 nm. The synthesis of
MUCNBs with UCNPs is based on a modiﬁed procedure
reported here for the synthesis of MFNBs with QDs.17 6.2 μL
of IONPs28 in chloroform (0.27 μM NPs concentration, d = 15
± 1 nm) and 5 μL of 23 ± 1 nm UCNPs in hexane or 10 μL of
7 ± 1 nm UCNPs in toluene (yttrium concentration was 3.1 g/
L for the 23 nm particles and 1.8 g/L for the 7 nm particles)
were transferred in an 8 mL open vial. The solvent was
evaporated by ﬂuxing nitrogen and the particles were
redispersed in 185 μL of THF. 15 μL of poly(maleic
anhydride-alt-1-octadecene) in THF (50 mM, this concen-
tration refers to the polymer monomer units) was added and
the mixture was shaken for 45 min (1000 rpm shaking rate),
keeping the vial open. Then, 0.8 mL of acetonitrile was added
dropwise at a ﬂow rate of 250 μL/min. After the bead
formation, the sample was cleaned by placing it on top of a
permanent magnet (0.3 T) overnight followed by the
redispersion of the nanobeads collected to the magnet in 500
μL of fresh water.
Synthesis of Magnetic Fluorescent Nanobeads
(MFNBs) with QDs. The synthesis of MFNBs with QDs is
based on a previous reported work.17 7 μL of manganese iron
oxide NPs29 in toluene (36.76 μM NPs concentration, d = 8 ±
1 nm) and 8.64 μL of cadmium selenide-zinc sulﬁde core−shell
QDs31 in toluene (40 μM NPs concentration, d = 6 ± 1 nm)
were put in an 8 mL open vial. The solvent was evaporated by
ﬂuxing nitrogen and the particles were redispersed in 175 μL of
THF. 25 μL of poly(maleic anhydride-alt-1-octadecene) in
THF (50 mM, this concentration refers to the polymer
monomer unit) were added and the mixture was shaken for 45
min (1000 rpm shaking rate). Then, 0.8 mL of acetonitrile was
added dropwise at a ﬂow rate of 250 μL/min. After the
nanobeads’ formation, the sample was cleaned initially by
placing it onto a permanent magnet (0.3 T) for 10 min to
remove the biggest beads, and then the supernatant was cleaned
again on the magnet overnight, followed by the redispersion of
the beads in 500 μL of fresh water.
Cell Culture. A431 epidermoid carcinoma and HeLa-WT
cervical cancer cell lines were cultured using Dulbecco’s
modiﬁed eagle’s medium (DMEM) supplemented with 10%
fetal bovine serum (FBS), 2% Penstrep, and 1% L-Glutamine at
37 °C and 5% CO2. The cells were grown to conﬂuency in T75
cell culture ﬂask.
Administration of MUCNBs and LDH Cytotoxicity
Assay. To measure the toxicity of the MUCNBs, both cell
types were washed using PBS, trypisized using Trypsin/EDTA
(0.025/0.01% in PBS), counted using NucleoCounter NC-
100TM (Chemometec), and plated in 24-well plates at a density
of 100 000 cells/well for 12 and 24 h time points. The cells
were then allowed to grow overnight in an incubator at 37 °C.
The next day the media on the cells was replaced with 500 μL
of 6, 12, or 24 μgFe/mL of MUCNBs per well, prepared by
diluting a stock solution of MUCNBs in water (1.51 mgFe/mL,
0.65 mgY/mL) in phenol-red free complete media. The use of
phenol-red free media ensured that the phenol-red indicator
would not interfere with our assays. The cell plates were then
placed in the sterile incubator at 37 °C with 5% CO2 and
allowed to grow for 12 and 24 h before carrying out the toxicity
assay. Separate wells were allocated for control experiments in
which no NPs were added (see later CTRL and POS CTRL).
Prior to starting the assay, a positive control (POS CTRL,
100% toxicity) was prepared. 50 μL of lysis buﬀer provided by
the kit manufacturer was added to the cell wells allocated for
the positive controls (POS CTRL) and incubated at 37 °C with
5% CO2 for 45 min. A negative control (CTRL) consists of
cells that was grown under the same conditions without
treatment with MUCNBs and with no disturbance. After the
respective time points, the cytotoxicity of the MUCNBs was
assessed using a Pierce LDH cytotoxicity assay kit (Themo-
Fisher Scientiﬁc). This assay was performed three times for
each condition. Later, the supernatant from each well (CTRL,
POS CTRL, 6, 12, and 24 μgFe/mL UCNPs) was collected in
an Eppendorf tube and centrifuged at 250g for 3 min. 50 μL
aliquots of these supernatants were then transferred to a clean
96 well plate, and 50 μL of LDH assay mix was added to each
well. The 96-well plate was then incubated at room temperature
in the dark for 30 min. Finally, after the incubation period, 50
μL of stop solution that was in the kit was added to each well
and absorbance was read at 490 and 680 nm (for background
correction) using a MultiSkan Go Multiplate Spectometer
(ThermoFisher Scientiﬁc). The percent toxicity was then
calculated using the formula given below after blank subtraction
and the mean values were plotted with respective error bars.26
Each data point was repeated three times for all groups (n = 3).
= −
−
− ×
%toxicity (experimental Abs value MUCNBs Abs value
CTRL Abs value)/(POS CTRL Abs value
CTRL Abs value) 100
in which Experimental Abs value is the absorption value of each
condition tested; MUCNBs Abs value is the absorption value of
24 μgFe/mL MUCNBs in cell media; CTRL Abs value is the
absorption value of the untreated cells; POS CTRL Abs value is
the absorption value of the positive control cells.
Stability of MUCNBs in Cell Media. To evaluate the
stability of MUCNBs in cell culture media, 15 μL of MUCNBs
(0.4 mgFe/mL) was added to 500 μL of phenyl-red free DMEM
medium containing 10% fetal bovine serum (FBS), and
incubated for an additional 6, 12, and 24 h, at 37 °C. After
the incubation periods, the MUCNBs were collected by a
permanent magnet (0.3T), redispersed in 500 μL of Milli-Q
water and the average hydrodynamic sizes were determined by
DLS (Figure S10a). The MUCNB solutions in water were then
left undisturbed for 6 additional hours and DLS measurements
were repeated (Figure S10b). DLS hydrodynamic diameters are
summarized in Table S4.
Elemental Analysis. An inductively coupled plasma atomic
emission spectrometer (ICP-AES, iCAP 6500, Thermo) was
used for the elemental analysis and the concentration
evaluation of magnetic, ﬂuorescent, and UCNPs. The samples
were prepared by an overnight digestion of 25 μL of sample
solution in 2.5 mL of aqua regia. Subsequently, the sample was
diluted with Milli-Q water to a ﬁnal volume of 25 mL.
TEM Characterization. Transmission electron microscopy
was performed on a JEOL JEM-1011 with an acceleration
voltage of 100 kV. The sample preparation was conducted by
drop-casting a droplet of the sample solution onto a carbon
coated copper grid with the subsequent removal of the solvent
by evaporation at room temperature.
Dynamic Light Scattering (DLS) Characterization.
Dynamic light scattering measurements were performed on a
Zetasizer Nano ZS90 (Malvern, USA) equipped with a 4.0 mW
He−Ne laser operating at 633 nm and an avalanche photodiode
detector. Measurements were conducted with a ZEN0112-low
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volume disposable sizing cuvette, setting 1.330 as the refractive
index and 0.8869 cP as the viscosity. The measurements were
performed with 173 backscatter (NIBS default) as angle of
detection, with an automatic scan time and three scans per
measurement.
Relaxivity Measurements. Water solutions of MFNBs,
MUCNBs, and IONPs with iron concentration ranging from
0.002 to 0.5 mM were prepared. The longitudinal (T1) and
transverse (T2) relaxation times were measured at 37 °C using a
Minispec spectrometer (Bruker, Germany) mq 60 (1.5 T)and a
9.4 T Biospec (Bruker, Germany) system equipped with a 400
mT/m gradient and a 40 mm quadrature bird-cage resonator.
The T1 relaxation proﬁle was obtained using an inversion−
recovery sequence, with 20 data points and 4 acquisitions for
each measurement. The T2 relaxation time was measured using
a Carr−Purcell Meiboom Gill (CPMG) spin−echo pulse
sequence with 200 data points with an inter echo time of 0.5
ms. The relaxivities ri (i = 1, 2) were determined by the
following equation:
= + =
T T
rC i
1 1
( 1, 2)
i i
i
(Obs) (H O)
Fe
2
in which CFe is the concentration of Fe ions. The values are
reproducible within a 5% deviation.
Confocal Microscopy. Confocal microscopy images were
acquired by an A1 Nikon Eclipse Ti microscope. For the
MFNBs, the microscope was equipped with an argon laser
source at 488 nm. However, to detect MUCNBs, a ﬁber
coupled CNI laser CW with a power emission of 150 mW
emitting at 980 nm was used. Images were recorded using an
acquisition window set at 525−700 nm for the red emitting
QDs and 500−700 nm for the UCNPs. For the analysis, the
nanobead samples were deposited by drop casting on a 75 × 25
mm microscope glass coverslip. To compare the eﬃcacy of
both ﬂuorescent and upconverting materials as luminescent
probes for tissues, confocal microscopy images were taken for
both kinds of nanobeads through diﬀerent materials: agarose
gel slices (2% in agarose) of diﬀerent thickness (0.8−2 and 4
mm) and mouse skin (0.45 mm thickness). In these
experiments the nanobead solutions were deposited on the
glass coverslip, and then the gel layer or the mouse skin was
placed on the glass and the nanobead solution was drop-cast
again on top of the gel or the mouse skin. Consequently, it was
possible to detect the presence of both types of MFNBs and
MUCNBs on the glass surface in addition to the top of the
diﬀerent materials with diﬀerent thicknesses. Under the same
conditions of excitation and emission used to detect the two
kinds of nanobeads, the diﬀerent substrates (agarose gel and
mouse skin) were also observed alone. Further analyses were
conducted on the MFNBs and MUCNBs deposited on agarose
gel layers according to the previous procedure, using a two-
photon confocal microscope Olympus FV1000MPE equipped
with a Ti:sapphire laser Spectra Physics MaiTai emitting at 970
nm with a pulse of 100 fs, a frequency of 80 MHz, and a power
emission of 500 mW. Steady-state upconversion spectroscopy
and lifetime measurements. Steady-state upconversion lumi-
nescence spectra and lifetime measurements of UCNPs and
MUCNBs were acquired in an Edinburgh FLS980 spectrom-
eter. Solution-phase samples were excited with a 2 W, 980 nm
laser. Time-dependent lifetime decays were initiated with
nanosecond laser pulses from the 980 nm laser and were
measured using the multichannel scaling (MCS) technique.
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